Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nurse-Led phone program aims to cut stroke risk in ghana

NCT ID NCT04404166

Disease control Sponsor: Northern California Institute of Research and Education Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a nurse-guided phone program for 500 recent stroke patients in Ghana to help them manage their blood pressure at home. The program included home blood pressure monitoring, medication reminders, and education on heart health. The goal was to see if this approach could improve long-term blood pressure control and reduce the risk of another stroke.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
phone-based home blood pressure monitoring, medication reminders, and patient education
What this could lead to
If successful, this could provide a low-cost, scalable way to improve blood pressure control and prevent further strokes in low-resource settings.
What could go wrong
This is a completed Phase 3 trial, but results may not apply to other regions or healthcare systems. The intervention relies on patient engagement and phone access, which may limit effectiveness for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

500 people

The number who actually took part.

Started

Oct 2020

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age ≥ 18 years (stroke is commoner above this age cut-off) * male or females (sex is a biologic variable of interest) * recent stroke (within one month of symptom onset)- stroke may be ischemic or hemorrhagic based on brain imaging or diagnosed clinically using the locally validated version of the 8-item questionnaire for verifying stroke free status (8-QVSFS) when neuroimaging is not feasible * uncontrolled HTN (SBP ≥ 140 mmHg at both the last clinical encounter post-stroke and the eligibility screening visit) - SBP is used as the selection variable since most African hypertensives \<60 years have systolic or combination systolic/ diastolic HTN and for most patients, controlling SBP also results in DBP control * patients or family carers should own a basic mobile phone that can receive text/audio messages. Exclusion Criteria: \- Any condition that would limit participation in follow up assessments, such as severe cognitive impairment/dementia (MMSE ≤24).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood pressure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder hypertensive disorder stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood pressure Cardiovascular diseases Stroke

Contacts and locations

Locations

  • Agogo Presbyterian Hospital

    Agogo, Ghana

  • Ankaase Methodist Hospital

    Aboaso, Ghana

  • Cape Coast Teaching Hospital

    Cape Coast, Ghana

  • Komfo Anokye Teaching Hospital

    Kumasi, Ghana

  • Korle Bu Teaching Hospital

    Accra, Ghana

  • Kumasi South Hospital

    Kumasi, Ghana

  • Kwadaso SDA Hospital

    Kumasi, Ghana

  • Kwame Nkrumah University of Science and Technology

    Kumasi, Ghana

  • Manhyia Government Hospital

    Kumasi, Ghana

  • Tafo Government Hospital

    Kumasi, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.